Amgen Reports Fourth Quarter And Full Year 2020 Financial Results

Go back to Amgen Reports Fourth Quarter And Full Year 2020 Financial Results

Amgen (AMGN) Tops Q4 EPS by 42c

February 2, 2021 4:02 PM EST

Amgen (NASDAQ: AMGN) reported Q4 EPS of $3.81, $0.42 better than the analyst estimate of $3.39. Revenue for the quarter came in at $6.6 billion versus the consensus estimate of $6.58 billion.

GUIDANCE:

Amgen sees FY2021 EPS of $16.00-$17.00, versus the consensus of $17.02. Amgen sees... More